HCA HCA Healthcare, Inc. Common Stock
Informazioni su HCA Healthcare, Inc. Common Stock Panoramica della società da Wikipedia
HCA Healthcare, Inc. is an American global for-profit operator of health care facilities that was founded in 1968. It is based in Nashville, Tennessee, and, as of May 2020, owned and operated 186 hospitals and approximately 2,400 sites of care, including surgery centers, freestanding emergency rooms, urgent care centers and physician clinics in 20 states and the United Kingdom. As of 2024, HCA Healthcare is ranked #61 on the Fortune 500 rankings of the largest United States corporations by total revenue. In the 1990s, the company engaged in illegal accounting and other crimes that resulted in the payment of more than $2 billion in federal fines and other penalties, and the dismissal of the CEO Rick Scott by the board of directors.
Leggi di più
HCA Healthcare, Inc. (historically known as Hospital Corporation of America) is an American global for-profit operator of health care facilities that was founded in 1968. It is based in Nashville, Tennessee, and, as of May 2020, owned and operated 186 hospitals and approximately 2,400 sites of care, including surgery centers, freestanding emergency rooms, urgent care centers and physician clinics in 20 states and the United Kingdom. As of 2024, HCA Healthcare is ranked #61 on the Fortune 500 rankings of the largest United States corporations by total revenue. In the 1990s, the company engaged in illegal accounting and other crimes that resulted in the payment of more than $2 billion in federal fines and other penalties, and the dismissal of the CEO Rick Scott by the board of directors.
History
Early years
The Hospital Corporation of America (HCA) was founded in 1968 in Nashville, Tennessee, by Thomas F. Frist Sr., Thomas F. Frist Jr. and Jack C. Massey. The founders envisioned a company that would bring together hospitals to deliver patient-focused care while using the combined resources of the organization to strengthen hospitals and improve the practice of medicine. The company began with Nashville's Park View Hospital, which the elder Frist had founded in 1960 with other doctors and where he was serving as chief executive.
The company included 11 hospitals when it filed its initial public offering on the New York Stock Exchange (NYSE) in 1969 and had 26 hospitals and 3,000 beds by the end of the year.
Growth and merger
The 1970s were characterized by rapid growth in the industry and for HCA Healthcare. In the early 1980s, the focus shifted to consolidation with HCA Healthcare acquiring General Care Corporation, General Health Services, Hospital Affiliates International and Health Care Corporation. By the end of 1981, the company operated 349 hospitals with more than 49,000 beds. Operating revenues had grown to $2.4 billion.
In 1987, HCA Healthcare, which had grown to operate 463 hospitals (255 owned and 208 managed), spun off HealthTrust, a privately owned, 104-hospital company. Believing its stock was undervalued, the company completed a $5.1 billion leveraged management buyout led by chairman Thomas F. Frist Jr. in 1988. HCA Healthcare re-emerged as a public company in 1992.
In February 1994, HCA Healthcare merged with Louisville, Kentucky-based Columbia Hospital Corporation, which earlier had acquired 73 hospitals of Galen Health Care from Humana,
to form Columbia/HCA Healthcare Corporation. Related names of note include HCA International and Health Corporation of America.
Columbia Hospital Corporation
In 1988, Rick Scott and Richard Rainwater each put up $125,000 in working capital in their new company, Columbia Hospital Corporation; they borrowed the remaining money needed to purchase two struggling hospitals in El Paso for $60 million. Then they acquired a neighboring hospital and shut it down. Within a year, the remaining two were doing much better. By the end of 1989, Columbia Hospital Corporation owned four hospitals with a total of 833 beds.
In 1992, Columbia made a stock purchase of Basic American Medical, which owned eight hospitals, primarily in southwestern Florida. In September 1993, Columbia did another stock purchase, worth $3.4 billion, of Galen Healthcare, which had been spun off by Humana Inc. several months earlier. At the time, Galen had approximately 90 hospitals. After the purchase, Galen stockholders had 82% of the stock in the combined company, with Scott still running the company.
Recent history
On November 17, 2006, HCA became a private company for the third time when it completed a merger in which the company was acquired by a private investor group including affiliates of Kohlberg Kravis Roberts and Bain Capital, together with Merrill Lynch and HCA Healthcare founder Thomas F. Frist Jr. The total transaction was valued at approximately $33 billion, making it the largest leveraged buyout in history at the time, eclipsing the 1989 buyout of RJR Nabisco.
In May 2010, HCA announced that the corporation would once again go public with an expected $4.6-billion IPO as HCA Holdings, Inc. In March 2011, HCA sold 126.2 million shares for $30 each, raising about $3.79 billion, at that time, the largest private-equity backed IPO in U.S. history. In May 2017, the corporation was renamed HCA Healthcare.
In December 2018, a historical marker was installed in the parking lot of HCA's Sarah Cannon Cancer Center in Nashville, formerly the location of HCA's first hospital, Park View Hospital.
In 2018, the company was ranked No. 67 in the 2019 Fortune 500 list of the largest United States corporations by total revenue.
In May 2021, the company finalized a deal with Google to develop healthcare algorithms using patient records. In August 2021, HCA announced a deal with venture capital firm General Catalyst to develop digital solutions to streamline workflows and improve patient care; as part of the deal, HCA sold its healthcare app development firm PatientKeeper to General Catalyst's portfolio company Commure.
In April 2022, HCA Healthcare announced a $1.5 million partnership with Florida International University's Nicole Wertheim college of Nursing and Health Sciences, to expand its facilities to address the national nursing shortage.
In October 2022, LCMC Health in partnership with Tulane University announced that it would acquire Tulane Medical Center, Lakeview Regional Medical Center, and Tulane Lakeside Hospital from HCA for $150 million pending regulatory approval.
In March 2024, it was announced HCA had completed the sale of West Hills Hospital and Medical Center and related assets in Los Angeles, California to UCLA Health, for an undisclosed amount.
Facilities
United States
As of 2024, HCA has 186 hospitals. They also report operating more than 2,400 additional sites of care, including surgery centers, freestanding ERs, urgent care centers, and physician clinics located in 20 U.S. states and in the United Kingdom. A significant portion of those hospitals are situated in Florida and Texas. As of 2022, HCA had 47 hospitals and 31 surgery centers in Florida, and 45 hospitals and 632 affiliated sites of care in Texas. In 2021, it announced plans to build 3 new hospitals in Florida. In 2022, The Dallas Morning News reported that HCA will build 5 new hospitals in Texas. They also have a strong presence in Tennessee, where it began. HCA had 13 hospitals there as of 2019.
Between 2003 and 2017, HCA did not enter any new markets. However, in July 2007, HCA sold its hospitals in Switzerland.
In 2017, HCA acquired the Memorial University Medical Center in Savannah, Georgia. That same year, they acquired three Houston, Texas, hospitals from Tenet Healthcare.
In 2019 they purchased Mission Health System which operates hospitals in North Carolina.
In January 2020, HCA Healthcare acquired Valify, a healthcare cost-management company. In May 2020, HCA acquired 49-bed Shands Starke (Fla.) Regional Medical Center and 25-bed Shands Live Oak (Fla.) Regional Medical Center from CHS. HCA is operating the two facilities as off-campus emergency departments of Lake City (Fla.) Medical Center and North Florida Regional Medical Center in Gainesville. Later that year, it signed an agreement to sell Garden Park Medical Center to Singing River Health System.
In 2021, HCA sold Redmond Regional Medical Center to AdventHealth for $635M, and four other Georgia hospitals to Piedmont Healthcare for $950 million. They also announced the acquisition of Meadows Regional Medical Center.
United Kingdom
HCA International, the UK arm of Hospital Corporation of America, "caters for around half of all private patients in London." The main hospital sites within the United Kingdom it operates include:
It opened urgent care walk-in centres at London Bridge Hospital and the Portland Hospital in March 2018. It claims that patients, on average, wait just seven minutes to see a nurse and 17 minutes to see a doctor. In February 2022, outsourced cleaning staff at London Bridge Hospital reported a lack of PPE, no access to sick pay, a lack of training and no prior warning about which rooms may be contaminated with the virus through the COVID-19 pandemic.
The Princess Grace Hospital specializes in breast cancer and surgery, aided by Kefah Mokbel and Nick Perry who, in 2005, founded The London Breast Institute.
The company opened The Harborne Hospital, a newly built private hospital located close to the Queen Elizabeth Hospital, Birmingham, in February 2024.
Significant areas of operation
Medical education
In recent years, HCA Healthcare has become a significant provider of clinical and medical education. It is the largest sponsor of graduate medical education programs in the U.S., with 56 teaching hospitals in 14 states, primarily in regions with a deficit of physician training programs. The company includes Research College of Nursing and Mercy School of Nursing, and has several advanced nursing simulation training centers. In early 2020, it completed the purchase of a majority stake in Galen College of Nursing, which operates 21 campuses in 12 states, offering Bachelor of Science and Associate of Science nursing degrees.
Controversies
Medicare billing practices lawsuit
In 1993, lawsuits were filed against HCA by former employees who alleged that the company had engaged in questionable Medicare billing practices. In 1997, with a federal investigation by the FBI, the IRS and the Department of Health and Human Services in its early stages, the Columbia/HCA board of directors forced Rick Scott to resign as chairman and CEO amid growing evidence that the company "had kept two sets of books, one to show the government and one with actual expenses listed." Thomas Frist, a co-founder of HCA and brother of U.S. Senator Bill Frist, returned to the company as CEO in 1997 and called on longtime friend and colleague Jack O. Bovender Jr. to help him turn the company around.
The federal probe culminated in 2003 with "the government receiving a total of over $2 billion in criminal fines and civil penalties for systematically defrauding federal health care programs." Columbia/HCA pleaded guilty to 14 felonies and admitted to systematically overcharging the government. The federal probe has been referred to as the longest and costliest investigation for health-care fraud in U.S. history.
2005 insider trading suit
In July 2005, U.S. Senator Bill Frist sold all of his HCA shares, which were held in a blind trust, two weeks before disappointing earnings sent the stock on a 9-point plunge. At the time, Frist was considering a run for president and said that he had sold his shares to avoid the appearance of a conflict of interest. When the company disclosed that other executives had also sold their shares during that same time, shareholders alleged that the company had made false claims about its profits to drive up the price, which then fell when the company reported disappointing financial results. Eleven of HCA's senior officers were sued for accounting fraud and insider trading. HCA settled the lawsuit in August 2007, agreeing to pay $20 million to the shareholders but admitting no wrongdoing, and no charges were brought.
COVID-19 PPE
During the COVID-19 pandemic in the United States, HCA hospital nurses and other workers spoke out about the lack of PPE. In April 2020, there was an outcry against HCA following the deaths of two nurses Celia Yap-Banago and Rosa Luna who worked at HCA hospitals in Kansas City and California and had contracted coronavirus, despite the alarm having been raised about the lack of PPE at work.
Mission Hospital Acquisition Complaints
On December 14, 2023, the North Carolina Attorney General sued HCA for violating the terms of an agreement that allowed HCA to purchase Mission Health.
On February 13, 2024, HCA Healthcare denied the allegations and asked a judge to dismiss the lawsuit by the Attorney General, and in return the hospital network filed a counterclaim against the Attorney General.
Fonte: Wikipedia (Inglese), CC BY-SA 4.0 · Vedi su Wikipedia ↗
HCA Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
HCA Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
Performance decennale Andamento di ricavi, utile netto, margini e EPS
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
Dividendi Rendimento, payout ratio, storico dividendi, CAGR 5Y
| Data ex-dividendo | Importo |
|---|---|
| 16 Giugno 2026 | $0,7800 |
| 17 Marzo 2026 | $0,7800 |
| 15 Dicembre 2025 | $0,7200 |
| 16 Settembre 2025 | $0,7200 |
| 16 Giugno 2025 | $0,7200 |
| 17 Marzo 2025 | $0,7200 |
| 13 Dicembre 2024 | $0,6600 |
| 16 Settembre 2024 | $0,6600 |
| 14 Giugno 2024 | $0,6600 |
| 14 Marzo 2024 | $0,6600 |
| 13 Dicembre 2023 | $0,6000 |
| 14 Settembre 2023 | $0,6000 |
| 15 Giugno 2023 | $0,6000 |
| 16 Marzo 2023 | $0,6000 |
| 13 Dicembre 2022 | $0,5600 |
| 15 Settembre 2022 | $0,5600 |
| 15 Giugno 2022 | $0,5600 |
| 16 Marzo 2022 | $0,5600 |
| 13 Dicembre 2021 | $0,4800 |
| 15 Settembre 2021 | $0,4800 |
HCA Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo
- Acquisto forte 6 20,0%
- Compra 11 36,7%
- Mantieni 12 40,0%
- Vendi 1 3,3%
- Vendita forte 0 0,0%
Target Price a 12 Mesi
21 analisti · 2026-08-17Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili
| Periodo | EPS Actual | EPS Stimato | Sorpresa |
|---|---|---|---|
| 30 Giugno 2026 | $7.62 | $7.54 | 0.08% |
| 31 Marzo 2026 | $7.15 | $7.21 | -0.06% |
| 31 Dicembre 2025 | $8.14 | $7.53 | 0.61% |
| 30 Settembre 2025 | $6.96 | $5.77 | 1.2% |
| 30 Giugno 2025 | $6.83 | $6.31 | 0.52% |
| 31 Marzo 2025 | $6.45 | $5.84 | 0.61% |
Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore
| Ticker | Capitalizzazione di Mercato | P/E | Rev YoY | Margine Netto | ROE | Margine lordo |
|---|---|---|---|---|---|---|
| HCA | $104.86B | 16.5 | 7.1% | 9.0% | -159.1% | — |
| THC | $17.28B | 12.8 | 3.1% | 11.1% | 56.4% | — |
| EHC | $10.61B | 19.2 | 10.5% | 9.5% | 25.1% | — |
| ENSG | $10.12B | 29.8 | 18.7% | 6.8% | 16.9% | — |
| UHS | — | 9.4 | 9.7% | 8.6% | 21.4% | — |
| PACS | $6.01B | 31.5 | 29.3% | 3.6% | 23.1% | — |
| CON | $2.53B | 15.1 | 13.9% | 7.7% | 49.8% | — |
| BKD | $2.57B | -9.6 | 2.2% | -8.2% | -313.2% | 26.2% |
| ACHC | $1.28B | -1.2 | 5.0% | -33.3% | -43.9% | — |
| SNDA | $612M | -7.7 | 25.2% | -18.6% | -197.2% | — |
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico 12
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $75.60B | $70.60B | $64.97B | $60.23B | $58.75B | $51.53B | $51.34B | $46.68B | $43.61B | $41.49B | |
| SG&A Expense | $548M | $421M | $353M | $307M | $337M | $416M | $370M | $344M | $340M | $343M | |
| Operating Expenses | $65.77B | $62.08B | $57.26B | $51.65B | $48.92B | $46.10B | $46.09B | $41.34B | $39.23B | $36.68B | |
| Interest Expense | $2.25B | $2.06B | $1.94B | $1.74B | $1.57B | $1.58B | $1.82B | $1.75B | $1.69B | $1.71B | |
| Pretax Income | $9.83B | $8.52B | $7.71B | $8.58B | $9.83B | $5.43B | $5.24B | $5.33B | $4.38B | $4.81B | |
| Income Tax | $2.05B | $1.87B | $1.61B | $1.75B | $2.11B | $1.04B | $1.10B | $946M | $1.64B | $1.38B | |
| Net Income | $6.78B | $5.76B | $5.24B | $5.64B | $6.96B | $3.75B | $3.50B | $3.79B | $2.22B | $2.89B | |
| EPS (Basic) | $28.70 | $22.27 | $19.25 | $19.43 | $21.52 | $11.10 | $10.27 | $10.90 | $6.12 | $7.53 | |
| EPS (Diluted) | $28.33 | $22.00 | $18.97 | $19.15 | $21.16 | $10.93 | $10.07 | $10.66 | $5.95 | $7.30 | |
| Shares (Basic) | 236,413,000 | 258,603,000 | 272,404,000 | 290,348,000 | 323,315,000 | 338,274,000 | 341,210,000 | 347,297,000 | 362,305,000 | 383,591,000 | |
| Shares (Diluted) | 239,495,000 | 261,806,000 | 276,412,000 | 294,666,000 | 328,752,000 | 343,605,000 | 348,226,000 | 355,303,000 | 372,221,000 | 395,851,000 | |
| EBITDA | $3.52B | $3.31B | $3.08B | $2.97B | $2.85B | $2.72B | $2.60B | $2.28B | $2.13B | $1.97B |
Stato Patrimoniale 22
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.04B | $1.93B | $935M | $908M | $1.45B | $1.79B | $621M | $502M | $732M | $646M | |
| Short-term Investments | · | · | · | · | · | $116M | $147M | $47M | $54M | $49M | |
| Receivables | $10.87B | $10.75B | $9.96B | $8.89B | $8.10B | $7.05B | $7.38B | $6.79B | $6.50B | $5.83B | |
| Inventory | $1.65B | $1.74B | $2.02B | $2.07B | $1.99B | $2.02B | $1.85B | $1.73B | $1.57B | $1.50B | |
| Other Current Assets | $2.22B | $1.99B | $2.01B | $1.78B | $2.01B | $1.46B | $1.35B | $1.19B | $1.17B | $1.11B | |
| Current Assets | $15.78B | $16.41B | $14.93B | $13.64B | $13.54B | $12.33B | $11.20B | $10.21B | $9.98B | $9.09B | |
| PP&E (Net) | $31.14B | $29.41B | $27.71B | $25.57B | $24.06B | $23.20B | $22.71B | $19.76B | $17.89B | $16.35B | |
| PP&E (Gross) | $66.28B | $62.51B | $58.55B | $54.76B | $51.35B | $49.32B | $47.23B | $42.97B | $40.08B | $37.05B | |
| Accum. Depreciation | $35.13B | $33.10B | $30.83B | $29.18B | $27.29B | $26.12B | $24.52B | $23.21B | $22.19B | $20.70B | |
| Other Non-current Assets | $255M | $230M | $184M | $298M | $598M | $546M | $480M | $690M | $710M | $1.07B | |
| Total Assets | $60.72B | $59.51B | $56.21B | $52.44B | $50.74B | $47.49B | $45.06B | $39.21B | $36.59B | $33.76B | |
| Accounts Payable | $4.66B | $4.28B | $4.23B | $4.24B | $4.11B | $3.54B | $2.90B | $2.58B | $2.61B | $2.32B | |
| Current Liabilities | $16.35B | $15.18B | $12.65B | $9.90B | $9.58B | $8.70B | $7.76B | $7.57B | $6.16B | $5.83B | |
| Capital Leases | $1.85B | $1.86B | $1.90B | $1.75B | $1.75B | $1.67B | $1.50B | · | · | · | |
| Total Liabilities | · | · | · | · | · | · | $45.62B | $42.12B | $41.59B | $39.39B | |
| Long-term Debt | $44.28B | $43.03B | $39.59B | $38.08B | $34.58B | $31.00B | $33.72B | $32.82B | $33.06B | $31.38B | |
| Total Debt | $41.60B | $43.03B | $39.59B | $38.08B | $34.58B | $31.00B | $33.72B | $32.82B | $33.06B | $31.38B | |
| Retained Earnings | $-5.72B | $-2.12B | $-1.35B | $-2.28B | $-532M | $777M | $-2.35B | $-4.57B | $-6.53B | $-6.97B | |
| AOCI | $-305M | $-387M | $-425M | $-490M | $-404M | $-502M | $-460M | $-381M | $-278M | $-338M | |
| Stockholders' Equity | $-6.03B | $-2.50B | $-1.77B | $-2.77B | $-933M | $572M | $-2.81B | $-4.95B | $-6.81B | $-7.30B | |
| Liabilities + Equity | $60.72B | $59.51B | $56.21B | $52.44B | $50.74B | $47.49B | $45.06B | $39.21B | $36.59B | $33.76B | |
| Shares Outstanding | 224,605,100 | 249,981,400 | 265,537,300 | 277,378,300 | 305,476,800 | 339,425,600 | 338,445,600 | 342,895,200 | 350,091,600 | 370,535,900 |
Flusso di cassa 17
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $3.52B | $3.31B | $3.08B | $2.97B | $2.85B | $2.72B | $2.60B | $2.28B | $2.13B | $1.97B | |
| Stock-based Comp | $401M | $360M | $262M | $341M | $440M | $362M | $347M | $268M | $270M | $251M | |
| Amort. of Intangibles | $12M | $16M | $20M | $44M | $25M | $26M | · | · | · | · | |
| Other Non-cash | $1.93B | $1.08B | $850M | $-431M | $-1.29B | $2.40B | $1.07B | $461M | $-3.53B | $-2.67B | |
| Operating Cash Flow | $12.64B | $10.51B | $9.43B | $8.52B | $8.96B | $9.23B | $7.60B | $6.76B | $5.43B | $5.65B | |
| CapEx | $4.94B | $4.88B | $4.74B | $4.39B | $3.58B | $2.83B | $4.16B | $3.57B | $3.02B | $2.76B | |
| Investing Cash Flow | $-4.99B | $-4.93B | $-5.32B | $-3.39B | $-2.64B | $-3.39B | $-5.72B | $-3.90B | $-4.28B | $-3.24B | |
| Debt Issued | $8.47B | $7.50B | $3.22B | $6.00B | $4.34B | $2.70B | $6.45B | $2.00B | $1.50B | $5.40B | |
| Net Debt Issued | $1.08B | $5.08B | $2.31B | $3.17B | $475M | $-737M | $1.13B | $296M | $749M | $925M | |
| Stock Repurchased | $10.07B | $6.04B | $3.81B | $7.00B | $8.21B | $441M | $1.03B | $1.53B | $2.05B | $2.75B | |
| Net Stock Activity | $-10.07B | $-6.04B | $-3.81B | $-7.00B | $-8.21B | $-441M | $-1.03B | $-1.53B | $-2.05B | $-2.75B | |
| Dividends Paid | $679M | $690M | $661M | $653M | $624M | $153M | $550M | $487M | $0 | · | |
| Financing Cash Flow | $-8.55B | $-4.58B | $-4.09B | $-5.66B | $-6.66B | $-4.68B | $-1.77B | $-3.08B | $-1.06B | $-2.51B | |
| Net Change in Cash | $-893M | $998M | $27M | $-543M | $-342M | $1.17B | $119M | $-230M | $86M | $-95M | |
| Taxes Paid | $1.74B | $1.84B | $1.39B | $1.18B | $2.18B | $1.00B | $849M | $872M | $1.21B | $1.25B | |
| Free Cash Flow | $7.69B | $5.64B | $4.69B | $4.13B | $5.38B | $6.40B | $3.44B | $3.19B | $2.41B | $2.89B | |
| Levered FCF | $5.91B | $4.03B | $3.16B | $2.74B | $4.15B | $5.12B | $2.00B | $1.74B | $1.35B | $1.68B |
Redditività 5
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Margin | 9.0% | 8.2% | 8.1% | 9.4% | 11.8% | 7.3% | 6.8% | 8.1% | · | · | |
| Pretax Margin | 13.0% | 12.1% | 11.9% | 14.2% | 16.7% | 10.5% | 10.2% | 11.4% | · | · | |
| EBITDA Margin | 4.7% | 4.7% | 4.7% | 4.9% | 4.9% | 5.3% | 5.1% | 4.9% | · | · | |
| ROA | 11.3% | 10.0% | 9.7% | 10.9% | 14.2% | 8.1% | 8.3% | 10.0% | 6.3% | 8.7% | |
| ROE | -159.1% | -269.6% | -230.9% | -305.0% | -3853.7% | -335.8% | -90.4% | -64.4% | -31.4% | -38.8% |
Liquidità e Solvibilità 4
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.0 | 1.1 | 1.2 | 1.4 | 1.4 | 1.4 | 1.4 | 1.3 | 1.6 | 1.6 | |
| Quick Ratio | 0.7 | 0.8 | 0.9 | 1.0 | 1.0 | 1.0 | 1.1 | 1.0 | 1.2 | 1.1 | |
| Debt / Equity | -6.9 | -17.2 | -22.3 | -13.8 | -37.1 | 54.2 | -12.0 | -6.6 | -4.9 | -4.3 | |
| LT Debt / Equity | -6.9 | -15.3 | -21.0 | -13.6 | -36.8 | 53.8 | -12.0 | -6.5 | -4.8 | -4.3 |
Efficienza 2
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.3 | 1.2 | 1.2 | 1.2 | 1.2 | 1.1 | 1.2 | 1.2 | · | · | |
| Receivables Turnover | 7.0 | 6.8 | 6.9 | 7.1 | 7.8 | 7.1 | 7.2 | 7.0 | · | · |
Tassi di Crescita 10
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 7.1% | 8.7% | 7.9% | 2.5% | 14.0% | · | · | · | · | · | |
| Revenue CAGR 3Y | 7.9% | 6.3% | 8.0% | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 8.0% | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 28.8% | 16.0% | -0.94% | -9.5% | 93.6% | · | · | · | · | · | |
| EPS CAGR 3Y | 13.9% | 1.3% | 20.2% | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 21.0% | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 17.8% | 9.9% | -7.1% | -18.9% | 85.3% | · | · | · | · | · | |
| Net Income CAGR 3Y | 6.3% | -6.1% | 11.8% | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 12.6% | · | · | · | · | · | · | · | · | · | |
| Dividend CAGR 5Y | 34.7% | · | · | · | · | · | · | · | · | · |
Valutazione (TTM) 17
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $75.60B | $70.60B | $64.97B | $60.23B | $58.75B | $51.53B | $51.34B | $46.68B | $43.61B | $41.49B | |
| Net Income TTM | $6.78B | $5.76B | $5.24B | $5.64B | $6.96B | $3.75B | $3.50B | $3.79B | $2.22B | $2.89B | |
| Market Cap | $104.86B | $75.03B | $71.88B | $66.56B | $78.48B | $55.82B | $50.03B | $42.67B | $30.75B | $27.43B | |
| Enterprise Value | $145.42B | $116.13B | $110.53B | $103.74B | $111.61B | $84.92B | $82.98B | $74.95B | $63.02B | $58.11B | |
| P/E | 16.5 | 13.6 | 14.3 | 12.5 | 12.1 | 15.0 | 14.7 | 11.7 | 14.8 | 10.1 | |
| P/S | 1.4 | 1.1 | 1.1 | 1.1 | 1.3 | 1.1 | 1.0 | 0.9 | 0.7 | 0.7 | |
| P/B | -17.4 | -30.0 | -40.5 | -24.1 | -84.1 | 97.6 | -17.8 | -8.6 | -4.5 | -3.8 | |
| P / Tangible Book | · | · | · | · | · | 97.6 | · | · | · | · | |
| P / Cash Flow | 8.3 | 7.1 | 7.6 | 7.8 | 8.8 | 6.0 | 6.6 | 6.3 | 5.7 | 4.9 | |
| P / FCF | 13.6 | 13.3 | 15.3 | 16.1 | 14.6 | 8.7 | 14.5 | 13.4 | 12.8 | 9.5 | |
| EV / EBITDA | 41.3 | 35.1 | 35.9 | 34.9 | 39.1 | 31.2 | 32.0 | 32.9 | 29.6 | 29.6 | |
| EV / FCF | 18.9 | 20.6 | 23.6 | 25.1 | 20.7 | 13.3 | 24.1 | 23.5 | 26.1 | 20.1 | |
| EV / Revenue | 1.9 | 1.6 | 1.7 | 1.7 | 1.9 | 1.6 | 1.6 | 1.6 | 1.4 | 1.4 | |
| Dividend Yield | 0.65% | 0.92% | 0.92% | 0.98% | 0.80% | 0.27% | 1.1% | 1.1% | 0.00% | · | |
| Earnings Yield | 6.1% | 7.3% | 7.0% | 8.0% | 8.2% | 6.7% | 6.8% | 8.6% | 6.8% | 9.9% | |
| Payout Ratio | 10.0% | 12.0% | 12.6% | 11.6% | 9.0% | 4.1% | 15.7% | 12.9% | · | · | |
| Annual Payout | $679M | $690M | $661M | $653M | $624M | $153M | $550M | $487M | $0 | · |
Conto Economico 12
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $20.23B | $19.11B | $19.51B | $19.16B | $18.61B | $18.32B | $18.29B | $17.49B | $17.49B | $17.34B | $17.30B | $16.21B | $15.86B | $15.59B | $15.50B | $14.97B | |
| SG&A Expense | $148M | $133M | $153M | $139M | $130M | $126M | $120M | $111M | $100M | $90M | $108M | $89M | $82M | $74M | $79M | $74M | |
| Operating Expenses | $17.74B | $16.82B | $16.84B | $16.74B | $16.19B | $15.99B | $16.15B | $15.58B | $15.26B | $15.09B | $14.96B | $14.58B | $14.05B | $13.67B | $12.20B | $13.27B | |
| Interest Expense | $599M | $584M | $572M | $561M | $568M | $547M | $528M | $515M | $506M | $512M | $491M | $483M | $485M | $479M | $453M | $446M | |
| Pretax Income | $2.49B | $2.29B | $2.67B | $2.42B | $2.42B | $2.33B | $2.13B | $1.91B | $2.24B | $2.25B | $2.35B | $1.63B | $1.81B | $1.92B | $3.30B | $1.70B | |
| Income Tax | $564M | $430M | $509M | $515M | $524M | $502M | $447M | $424M | $550M | $445M | $484M | $355M | $397M | $379M | $656M | $360M | |
| Net Income | $1.70B | $1.62B | $1.88B | $1.64B | $1.65B | $1.61B | $1.44B | $1.27B | $1.46B | $1.59B | $1.61B | $1.08B | $1.19B | $1.36B | $2.08B | $1.13B | |
| EPS (Basic) | $7.70 | $7.25 | $8.22 | $7.05 | $6.91 | $6.52 | $5.72 | $4.94 | $5.60 | $6.01 | $6.00 | $3.98 | $4.35 | $4.92 | $7.30 | $3.97 | |
| EPS (Diluted) | $7.62 | $7.15 | $8.09 | $6.96 | $6.83 | $6.45 | $5.66 | $4.88 | $5.53 | $5.93 | $5.92 | $3.91 | $4.29 | $4.85 | $7.20 | $3.91 | |
| Shares (Basic) | 220,538,000 | 223,588,000 | -482,587,000 | 232,891,000 | 239,173,000 | 246,936,000 | -523,751,000 | 256,763,000 | 261,156,000 | 264,435,000 | -550,173,000 | 271,173,000 | 274,494,000 | 276,910,000 | -590,583,000 | 285,958,000 | |
| Shares (Diluted) | 222,828,000 | 226,652,000 | -488,037,000 | 236,181,000 | 241,911,000 | 249,440,000 | -530,198,000 | 259,917,000 | 264,071,000 | 268,016,000 | -558,171,000 | 275,424,000 | 278,198,000 | 280,961,000 | -598,621,000 | 289,852,000 | |
| EBITDA | $944M | $930M | · | $889M | $863M | $860M | · | $842M | $819M | $795M | · | $769M | $763M | $756M | · | $749M |
Stato Patrimoniale 20
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.01B | $940M | $1.04B | $997M | $939M | $1.06B | $1.93B | $2.89B | $831M | $1.28B | · | $891M | $862M | $842M | · | $999M | |
| Receivables | $12.28B | $11.32B | $10.87B | $10.43B | $10.46B | $11.09B | $10.75B | $9.91B | $10.24B | $10.04B | · | $9.18B | $8.71B | $8.66B | · | $8.55B | |
| Inventory | $1.66B | $1.68B | $1.65B | $1.73B | $1.79B | $1.79B | $1.74B | $1.78B | $1.80B | $1.90B | · | $2.03B | $2.05B | $2.08B | · | $2.01B | |
| Other Current Assets | $2.23B | $2.11B | $2.22B | $2.13B | $2.37B | $2.32B | $1.99B | $2.08B | $2.30B | $2.05B | · | $2.19B | $2.26B | $1.96B | · | $1.92B | |
| Current Assets | $17.19B | $16.05B | $15.78B | $15.29B | $15.56B | $16.26B | $16.41B | $16.66B | $15.17B | $15.28B | · | $14.29B | $13.89B | $13.54B | · | $13.48B | |
| PP&E (Net) | $31.82B | $31.47B | $31.14B | $30.57B | $30.12B | $29.74B | $29.41B | $29.05B | $28.64B | $28.10B | · | $27.12B | $26.64B | $26.05B | · | $24.98B | |
| PP&E (Gross) | $68.41B | $67.36B | $66.28B | $65.49B | $64.39B | $63.68B | $62.51B | $61.75B | $60.62B | $59.44B | · | $57.77B | $56.67B | $55.46B | · | $53.73B | |
| Accum. Depreciation | $36.59B | $35.89B | $35.13B | $34.92B | $34.27B | $33.94B | $33.10B | $32.70B | $31.99B | $31.34B | · | $30.66B | $30.02B | $29.41B | · | $28.75B | |
| Other Non-current Assets | $258M | $326M | $255M | $277M | $236M | $226M | $230M | $309M | $240M | $199M | · | $200M | $196M | $319M | · | $461M | |
| Total Assets | $63.25B | $61.45B | $60.72B | $59.75B | $59.54B | $59.80B | $59.51B | $59.46B | $57.38B | $56.96B | $56.21B | $54.59B | $53.59B | $52.71B | $52.44B | $51.48B | |
| Accounts Payable | $4.75B | $4.81B | $4.66B | $4.55B | $4.25B | $4.49B | $4.28B | $4.24B | $4.03B | $4.74B | · | $4.14B | $3.82B | $3.77B | · | $4.16B | |
| Current Liabilities | $17.31B | $19.26B | $16.35B | $17.90B | $15.94B | $13.63B | $15.18B | $14.90B | $14.30B | $13.14B | · | $12.41B | $11.54B | $11.03B | · | $9.78B | |
| Capital Leases | $1.83B | $1.82B | $1.85B | $1.84B | $1.88B | $1.86B | $1.86B | $1.92B | $1.89B | $1.91B | · | $1.78B | $1.81B | $1.72B | · | $1.76B | |
| Long-term Debt | $45.83B | $44.37B | $44.28B | $42.60B | $42.70B | $44.58B | $43.03B | $42.97B | $40.88B | $40.19B | · | $39.35B | $38.93B | $38.86B | · | $37.71B | |
| Total Debt | $43.45B | $39.49B | · | $38.40B | $39.38B | $44.58B | · | $42.97B | $40.88B | $40.19B | · | $39.35B | $38.93B | $38.86B | · | $37.71B | |
| Retained Earnings | $-6.31B | $-5.98B | $-5.72B | $-5.02B | $-4.09B | $-3.16B | $-2.12B | $-1.81B | $-1.17B | $-1.19B | · | $-1.99B | $-1.85B | $-2.03B | · | $-2.78B | |
| AOCI | $-334M | $-327M | $-305M | $-317M | $-309M | $-357M | $-387M | $-378M | $-433M | $-433M | $-425M | $-491M | $-456M | $-470M | $-490M | $-592M | |
| Stockholders' Equity | $-6.64B | $-6.30B | $-6.03B | $-5.33B | $-4.39B | $-3.52B | $-2.50B | $-2.18B | $-1.60B | $-1.61B | · | $-2.48B | $-2.30B | $-2.50B | · | $-3.37B | |
| Liabilities + Equity | $63.25B | $61.45B | $60.72B | $59.75B | $59.54B | $59.80B | $59.51B | $59.46B | $57.38B | $56.96B | · | $54.59B | $53.59B | $52.71B | · | $51.48B | |
| Shares Outstanding | 217,963,300 | 222,530,900 | 224,605,100 | 229,845,100 | 236,143,900 | 242,955,400 | 249,981,400 | 254,517,700 | 259,237,600 | 263,215,800 | · | 268,967,300 | 272,931,700 | 275,939,900 | · | 283,903,500 |
Flusso di cassa 16
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $944M | $930M | $911M | $889M | $863M | $860M | $856M | $842M | $819M | $795M | $789M | $769M | $763M | $756M | $750M | $749M | |
| Stock-based Comp | $85M | $86M | $100M | $104M | $99M | $98M | $85M | $76M | $112M | $87M | $57M | $72M | $56M | $77M | $83M | $87M | |
| Other Non-cash | · | $-622M | · | · | · | $-917M | · | · | · | $-4M | · | · | · | $-393M | · | · | |
| Operating Cash Flow | $2.33B | $2.01B | $2.36B | $4.42B | $4.21B | $1.65B | $2.56B | $3.52B | $1.97B | $2.47B | $2.67B | $2.48B | $2.48B | $1.80B | $2.53B | $3.02B | |
| CapEx | $1.23B | $1.12B | $1.49B | $1.29B | $1.18B | $991M | $1.28B | $1.19B | $1.28B | $1.12B | $1.16B | $1.15B | $1.24B | $1.20B | $1.32B | $1.13B | |
| Investing Cash Flow | $-1.56B | $-1.28B | $-1.32B | $-1.39B | $-1.25B | $-1.03B | $-1.35B | $-1.35B | $-1.33B | $-903M | $-1.60B | $-1.31B | $-1.26B | $-1.15B | $-793M | $-546M | |
| Debt Issued | $2.99B | $0 | $3.24B | $0 | $0 | $5.23B | $0 | $3.01B | $0 | $4.48B | $4M | $2M | $3.22B | $0 | $21M | $10M | |
| Net Debt Issued | · | $-58M | · | · | · | $1.34B | · | · | · | $2.42B | · | · | · | $-550M | · | · | |
| Stock Repurchased | $2.06B | $1.57B | $2.56B | $2.50B | $2.50B | $2.51B | $1.70B | $1.79B | $1.37B | $1.18B | $910M | $1.14B | $915M | $846M | $1.52B | $698M | |
| Net Stock Activity | · | $-1.57B | · | · | · | $-2.51B | · | · | · | $-1.18B | · | · | · | $-846M | · | · | |
| Dividends Paid | $171M | $183M | $162M | $166M | $171M | $180M | $165M | $169M | $171M | $185M | $160M | $162M | $164M | $175M | $156M | $160M | |
| Financing Cash Flow | $-704M | $-830M | $-999M | $-2.97B | $-3.09B | $-1.50B | $-2.16B | $-110M | $-1.09B | $-1.22B | $-1.04B | $-1.13B | $-1.20B | $-725M | $-1.84B | $-2.32B | |
| Net Change in Cash | $73M | $-100M | $43M | $58M | $-121M | $-873M | $-955M | $2.06B | $-453M | $349M | $44M | $29M | $20M | $-66M | $-91M | $141M | |
| Taxes Paid | $730M | $-5M | $1.51B | $81M | $136M | $10M | $358M | $487M | $998M | $1M | $316M | $297M | $766M | $7M | $244M | $322M | |
| Free Cash Flow | · | $895M | · | · | · | $660M | · | · | · | $1.35B | · | · | · | $606M | · | · | |
| Levered FCF | · | $421M | · | · | · | $231M | · | · | · | $940M | · | · | · | $221M | · | · |
Redditività 5
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Margin | 8.4% | 8.5% | · | 8.6% | 8.9% | 8.8% | · | 7.3% | 8.3% | 9.2% | · | 6.7% | 7.5% | 8.7% | · | 7.6% | |
| Pretax Margin | 12.3% | 12.0% | · | 12.6% | 13.0% | 12.7% | · | 10.9% | 12.8% | 13.0% | · | 10.1% | 11.4% | 12.3% | · | 11.4% | |
| EBITDA Margin | 4.7% | 4.9% | · | 4.6% | 4.6% | 4.7% | · | 4.8% | 4.7% | 4.6% | · | 4.7% | 4.8% | 4.9% | · | 5.0% | |
| ROA | 2.8% | 2.7% | · | 2.8% | 2.8% | 2.8% | · | 2.2% | 2.6% | 2.9% | · | 2.0% | 2.3% | 2.6% | · | 2.2% | |
| ROE | -30.8% | -33.0% | · | -43.7% | -55.2% | -62.7% | · | -54.5% | -74.9% | -77.4% | · | -36.9% | -39.9% | -60.2% | · | -55.8% |
Liquidità e Solvibilità 4
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.0 | 0.8 | · | 0.9 | 1.0 | 1.2 | · | 1.1 | 1.1 | 1.2 | · | 1.2 | 1.2 | 1.2 | · | 1.4 | |
| Quick Ratio | 0.8 | 0.6 | · | 0.6 | 0.7 | 0.9 | · | 0.9 | 0.8 | 0.9 | · | 0.8 | 0.8 | 0.9 | · | 1.0 | |
| Debt / Equity | -6.5 | -6.3 | · | -7.2 | -9.0 | -12.7 | · | -19.7 | -25.6 | -24.9 | · | -15.9 | -16.9 | -15.6 | · | -11.2 | |
| LT Debt / Equity | -6.5 | -6.3 | · | -7.2 | -9.0 | -11.7 | · | -17.5 | -22.7 | -23.0 | · | -14.9 | -15.9 | -14.6 | · | -11.1 |
Efficienza 2
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | |
| Receivables Turnover | 1.8 | 1.7 | · | 1.9 | 1.8 | 1.7 | · | 1.8 | 1.8 | 1.9 | · | 1.8 | 1.8 | 1.8 | · | 1.8 |
Valutazione (TTM) 14
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $77.11B | $75.20B | · | $73.57B | $71.91B | $70.64B | · | $68.53B | $66.91B | $65.00B | · | $62.64B | $61.24B | $60.33B | · | $60.01B | |
| Net Income TTM | $6.62B | $6.53B | · | $6.18B | $5.99B | $5.93B | · | $5.40B | $5.32B | $5.23B | · | $4.77B | $4.84B | $4.92B | · | $5.83B | |
| Market Cap | $84.98B | $105.31B | · | $97.96B | $90.47B | $83.95B | · | $103.44B | $83.29B | $87.79B | · | $66.16B | $82.83B | $72.76B | · | $52.18B | |
| Enterprise Value | $127.42B | $143.86B | · | $135.36B | $128.91B | $127.47B | · | $143.52B | $123.34B | $126.70B | · | $104.62B | $120.90B | $110.77B | · | $88.89B | |
| P/E | 13.7 | 17.3 | · | 17.0 | 16.2 | 15.2 | · | 20.1 | 16.3 | 17.6 | · | 14.5 | 17.9 | 15.7 | · | 9.7 | |
| P/S | 1.1 | 1.4 | · | 1.3 | 1.3 | 1.2 | · | 1.5 | 1.2 | 1.4 | · | 1.1 | 1.4 | 1.2 | · | 0.9 | |
| P/B | -12.8 | -16.7 | · | -18.4 | -20.6 | -23.9 | · | -47.4 | -52.1 | -54.4 | · | -26.7 | -36.0 | -29.2 | · | -15.5 | |
| P / Cash Flow | · | 52.3 | · | · | · | 50.8 | · | · | · | 35.6 | · | · | · | 40.4 | · | · | |
| P / FCF | · | 117.7 | · | · | · | 127.2 | · | · | · | 65.0 | · | · | · | 120.1 | · | · | |
| EV / EBITDA | 135.0 | 154.7 | · | 152.3 | 149.4 | 148.2 | · | 170.5 | 150.6 | 159.4 | · | 136.0 | 158.5 | 146.5 | · | 118.7 | |
| EV / FCF | · | 160.7 | · | · | · | 193.1 | · | · | · | 93.8 | · | · | · | 182.8 | · | · | |
| EV / Revenue | 1.7 | 1.9 | · | 1.8 | 1.8 | 1.8 | · | 2.1 | 1.8 | 1.9 | · | 1.7 | 2.0 | 1.8 | · | 1.5 | |
| Earnings Yield | 7.3% | 5.8% | · | 5.9% | 6.2% | 6.6% | · | 5.0% | 6.1% | 5.7% | · | 6.9% | 5.6% | 6.4% | · | 10.3% | |
| Payout Ratio | · | 11.3% | · | · | · | 11.2% | · | · | · | 11.6% | · | · | · | 12.8% | · | · |
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
Conto Economico
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ricavi | $75.60B | $70.60B | $64.97B | $60.23B | $58.75B |
| Utile netto | $6.78B | $5.76B | $5.24B | $5.64B | $6.96B |
| EPS Diluito | $28.33 | $22.00 | $18.97 | $19.15 | $21.16 |
Stato Patrimoniale
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Debito / Patrimonio Netto | -6.9 | -17.2 | -22.3 | -13.8 | -37.1 |
| Rapporto corrente | 1.0 | 1.1 | 1.2 | 1.4 | 1.4 |
| Quick Ratio | 0.7 | 0.8 | 0.9 | 1.0 | 1.0 |
Flusso di cassa
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flusso di cassa libero | $7.69B | $5.64B | $4.69B | $4.13B | $5.38B |
Ultime notizie Notizie recenti che menzionano questa società
- Could HCA Healthcare, Inc. (HCA) Stock Rebound After Guidance Cuts and Payer Pressure?
- Bernstein Remains Bullish On HCA Healthcare (HCA); Projects EBITDA Growth Of 2.8% and 4.6% in 2026 And 2027
- HCA Healthcare (HCA) Reports Q1 2026 Financial Growth With $19.1B in Revenue
- Attività Notable delle Opzioni Giovedì: HCA, HRTG, ZM
- Strategia di Finanziamento di HCA Healthcare (HCA) si Espande – Ecco Come
- HCA Healthcare supera le stime di profitto trimestrale grazie alla domanda di assistenza medica
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
Scegli le metriche che contano per te — fai clic sul ➕ accanto a qualsiasi riga nei Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.
Proprietari istituzionali (13F) 1.486 filer · $39.4B totale · Aggiornato al 30 Giugno 2026
Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.
| Nuove posizioni | Posizioni chiuse | Aumentato | Diminuito | Variazione netta delle azioni |
|---|---|---|---|---|
| 128 (-51 vs trimestre precedente) | 174 (+70 vs trimestre precedente) | 450 (-30 vs trimestre precedente) | 555 (-4 vs trimestre precedente) | +16.3M |
Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.
| Istituzione | Valore | Azioni | % di 13F tracciati | Tipo |
|---|---|---|---|---|
| VANGUARD GROUP INC | $6.118.113.464 | 13.104.814 | 15,52% | Azioni |
| VANGUARD CAPITAL MANAGEMENT LLC | $3.954.150.533 | 10.141.708 | 10,03% | Azioni |
| Sanders Capital, LLC | $3.442.060.818 | 8.828.287 | 8,73% | Azioni |
| STATE STREET CORP | $2.912.102.056 | 7.469.035 | 7,39% | Azioni |
| WELLINGTON MANAGEMENT GROUP LLP | $1.750.298.867 | 4.489.212 | 4,44% | Azioni |
| GEODE CAPITAL MANAGEMENT, LLC | $1.225.259.672 | 3.159.159 | 3,11% | Azioni |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1.057.704.509 | 2.712.828 | 2,68% | Azioni |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $861.456.107 | 2.209.485 | 2,19% | Azioni |
| NORGES BANK | $836.457.140 | 2.145.367 | 2,12% | Azioni |
| Capital World Investors | $770.864.224 | 1.977.121 | 1,96% | Azioni |
| Capital International Investors | $747.403.041 | 1.916.947 | 1,90% | Azioni |
| Crake Asset Management LLP | $449.072.183 | 1.151.792 | 1,14% | Azioni |
| Metropolis Capital Ltd | $430.915.307 | 910.564 | 1,09% | Azioni |
| Darsana Capital Partners LP | $428.879.000 | 1.100.000 | 1,09% | Azioni |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $414.533.777 | 1.063.207 | 1,05% | Azioni |
| Life Cycle Investment Partners Ltd | $355.737.196 | 912.404 | 0,90% | Azioni |
| VANGUARD FIDUCIARY TRUST CO | $339.685.814 | 871.235 | 0,86% | Azioni |
| FMR LLC | $325.199.295 | 834.080 | 0,83% | Azioni |
| BARCLAYS PLC | $299.888.573 | 769.162 | 0,76% | Azioni |
| LYRICAL ASSET MANAGEMENT LP | $255.015.742 | 654.071 | 0,65% | Azioni |
| BlackRock, Inc. | $240.062.291 | 615.718 | 0,61% | Azioni |
| ROYAL LONDON ASSET MANAGEMENT LTD | $235.649.908 | 604.401 | 0,60% | Azioni |
| National Pension Service | $230.650.346 | 591.578 | 0,59% | Azioni |
| NORDEA INVESTMENT MANAGEMENT AB | $230.189.125 | 594.466 | 0,58% | Azioni |
| GOLDMAN SACHS GROUP INC | $209.775.669 | 538.038 | 0,53% | Azioni |
| Gobi Capital LLC | $195.742.325 | 502.045 | 0,50% | Azioni |
| Cryder Capital Partners LLP | $194.561.738 | 499.017 | 0,49% | Azioni |
| Swiss National Bank | $172.097.446 | 441.400 | 0,44% | Azioni |
| AustralianSuper Pty Ltd | $159.635.782 | 409.438 | 0,41% | Azioni |
| Consulta Ltd | $155.956.000 | 400.000 | 0,40% | Azioni |
| LEE DANNER & BASS INC | $152.150.679 | 390.240 | 0,39% | Azioni |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $151.472.265 | 388.500 | 0,38% | Opzione Call |
| Mitsubishi UFJ Asset Management Co., Ltd. | $147.943.761 | 379.450 | 0,38% | Azioni |
| DIMENSIONAL FUND ADVISORS LP | $139.697.405 | 358.300 | 0,35% | Azioni |
| Vanguard Global Advisers, LLC | $136.962.509 | 351.285 | 0,35% | Azioni |
| VIRGINIA RETIREMENT SYSTEMS ET Al | $134.838.505 | 288.820 | 0,34% | Azioni |
| ALLIANCEBERNSTEIN L.P. | $134.459.788 | 284.126 | 0,34% | Azioni |
| Sumitomo Mitsui Trust Group, Inc. | $132.794.974 | 340.596 | 0,34% | Azioni |
| TD Asset Management Inc | $131.847.152 | 338.165 | 0,33% | Azioni |
| Legal & General Group Plc | $127.805.162 | 327.798 | 0,32% | Azioni |
| California Public Employees Retirement System | $124.133.958 | 318.382 | 0,31% | Azioni |
| LAZARD ASSET MANAGEMENT LLC | $120.619.879 | 309.369 | 0,31% | Azioni |
| JANE STREET GROUP, LLC | $119.540.274 | 306.600 | 0,30% | Opzione Call |
| VANGUARD ASSET MANAGEMENT, Ltd | $116.069.863 | 297.699 | 0,29% | Azioni |
| CAPTRUST FINANCIAL ADVISORS | $114.741.071 | 294.291 | 0,29% | Azioni |
| ANTIPODES PARTNERS Ltd | $113.045.096 | 289.941 | 0,29% | Azioni |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $109.718.328 | 231.845 | 0,28% | Azioni |
| CITADEL ADVISORS LLC | $105.660.190 | 271.000 | 0,27% | Opzione Call |
| RHUMBLINE ADVISERS | $97.580.413 | 250.277 | 0,25% | Azioni |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | $97.026.076 | 248.855 | 0,25% | Azioni |
| MACKENZIE FINANCIAL CORP | $93.597.383 | 240.061 | 0,24% | Azioni |
| BloombergSen Inc. | $93.160.317 | 238.940 | 0,24% | Azioni |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $92.247.974 | 236.600 | 0,23% | Opzione Put |
| Brandywine Global Investment Management, LLC | $89.380.814 | 191.451 | 0,23% | Azioni |
| BANK OF AMERICA CORP /DE/ | $89.069.981 | 228.449 | 0,23% | Azioni |
| NEUBERGER BERMAN GROUP LLC | $85.926.216 | 220.386 | 0,22% | Azioni |
| MILFORD FUNDS LTD | $82.165.029 | 210.739 | 0,21% | Azioni |
| Bridgewater Associates, LP | $79.227.208 | 203.204 | 0,20% | Azioni |
| Prana Capital Management, LP | $75.552.494 | 193.779 | 0,19% | Azioni |
| DANSKE BANK A/S | $73.238.497 | 187.844 | 0,19% | Azioni |
| FRANKLIN RESOURCES INC | $70.965.828 | 182.015 | 0,18% | Azioni |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | $70.445.715 | 180.681 | 0,18% | Azioni |
| Quantinno Capital Management LP | $70.407.055 | 180.581 | 0,18% | Azioni |
| ARGENT CAPITAL MANAGEMENT LLC | $69.149.681 | 177.357 | 0,18% | Azioni |
| Retirement Systems of Alabama | $68.081.812 | 174.618 | 0,17% | Azioni |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $66.167.842 | 169.709 | 0,17% | Azioni |
| BNP PARIBAS FINANCIAL MARKETS | $64.793.090 | 166.183 | 0,16% | Azioni |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $64.665.206 | 165.855 | 0,16% | Azioni |
| HSBC HOLDINGS PLC | $64.431.534 | 165.332 | 0,16% | Azioni |
| AVIVA PLC | $64.264.789 | 164.828 | 0,16% | Azioni |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $64.194.533 | 135.649 | 0,16% | Azioni |
| SEB Asset Management AB | $63.257.255 | 162.244 | 0,16% | Azioni |
| TODD ASSET MANAGEMENT LLC | $62.567.208 | 160.474 | 0,16% | Azioni |
| Swedbank AB | $62.528.998 | 160.376 | 0,16% | Azioni |
| W1M Investment Management Ltd | $61.247.490 | 143.647 | 0,16% | Azioni |
| HARRIS ASSOCIATES L P | $60.080.879 | 154.097 | 0,15% | Azioni |
| Ensign Peak Advisors, Inc | $58.372.381 | 149.715 | 0,15% | Azioni |
| NEW YORK STATE COMMON RETIREMENT FUND | $57.747.778 | 148.113 | 0,15% | Azioni |
| CITADEL ADVISORS LLC | $57.235.852 | 146.800 | 0,15% | Opzione Put |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $57.160.993 | 146.800 | 0,15% | Azioni |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $56.512.217 | 144.944 | 0,14% | Azioni |
| Pictet Asset Management Holding SA | $52.147.803 | 133.739 | 0,13% | Azioni |
| VICTORY CAPITAL MANAGEMENT INC | $50.752.761 | 130.172 | 0,13% | Azioni |
| Pentwater Capital Management LP | $50.685.700 | 130.000 | 0,13% | Azioni |
| D. E. Shaw & Co., Inc. | $50.554.307 | 129.663 | 0,13% | Azioni |
| APG Asset Management N.V. | $50.368.550 | 147.699 | 0,13% | Azioni |
| AMF Tjanstepension AB | $50.355.853 | 129.154 | 0,13% | Azioni |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $50.349.225 | 129.137 | 0,13% | Azioni |
| EQUITABLE TRUST CO | $49.147.974 | 126.056 | 0,12% | Azioni |
| ENVESTNET ASSET MANAGEMENT INC | $48.919.124 | 125.469 | 0,12% | Azioni |
| CANADA PENSION PLAN INVESTMENT BOARD | $48.197.812 | 123.619 | 0,12% | Azioni |
| AMERICAN CENTURY COMPANIES INC | $47.460.140 | 121.727 | 0,12% | Azioni |
| OpenArc Corporate Advisory, LLC | $47.210.610 | 121.087 | 0,12% | Azioni |
| L1 Capital International Pty Ltd | $46.121.648 | 118.294 | 0,12% | Azioni |
| FIRST TRUST ADVISORS LP | $44.251.579 | 113.498 | 0,11% | Azioni |
| PFA Pension, Forsikringsaktieselskab | $44.046.098 | 112.971 | 0,11% | Azioni |
| United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund | $43.830.264 | 112.417 | 0,11% | Azioni |
| EP Wealth Advisors, LLC | $43.287.826 | 111.026 | 0,11% | Azioni |
| WOLVERINE TRADING, LLC | $42.597.104 | 101.200 | 0,11% | Opzione Call |
| MERCER GLOBAL ADVISORS INC /ADV | $42.302.070 | 108.497 | 0,11% | Azioni |
Insider aziendali 91 insider · 54 dirigenti · 31 direttori
| Insider | Ruolo | Ultima attività | Azioni possedute | Acquisti 12m | Vendite 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Samuel N Hazen | CEO | 10 Febbraio 2026 F | 64.842 | 0 | 7 | $-21.483.290 |
| O'Boyle Michael P | President & CEO - Parallon | 26 Febbraio 2013 A | 21.429 | 0 | 0 | $0 |
| Mike A Marks | EVP and CFO | 07 Maggio 2026 G | 46.576 | 0 | 0 | $0 |
| Bill B Rutherford | CFO and EVP | 16 Febbraio 2024 F | 22.251 | 0 | 0 | $0 |
| Russell K Harms | CFO - Central Group | 17 Novembre 2006 D | 0 | 0 | 0 | $0 |
| Robert Samuel Hankins JR | CFO-Outpatient Services Group | 17 Novembre 2006 D | 0 | 0 | 0 | $0 |
| Richard J Shallcross | CFO - Western Group | 17 Novembre 2006 D | 0 | 0 | 0 | $0 |
| Jeffrey T Crudele | CFO-Eastern Division | 01 Luglio 2005 F | 13.865 | 0 | 0 | $0 |
| Erol R Akdamar | Group President | 12 Novembre 2024 M | 6.843 | 0 | 0 | $0 |
| Timothy M Mcmanus | Group President | 31 Luglio 2024 M | 27.008 | 0 | 0 | $0 |
| Richard A Hammett | Group President | 16 Febbraio 2024 F | 17.936 | 0 | 0 | $0 |
| Charles J Hall | Group President | 11 Novembre 2022 M | 202.443 | 0 | 0 | $0 |
| Bruce A Moore JR | Group President - Service Line | 11 Novembre 2022 S | 30.807 | 0 | 0 | $0 |
| Paul W Rutledge | Group President | 31 Dicembre 2012 A | 335.657 | 0 | 0 | $0 |
| Beverly B Wallace | President - Parallon | 02 Novembre 2011 M | 144.714 | 0 | 0 | $0 |
| Charles Robert Evans | President - Eastern Group | 26 Luglio 2006 A | 62.173 | 0 | 0 | $0 |
| Marilyn B Tavenner | President-Outpatient Svcs Grp | 27 Ottobre 2005 A | 26.154 | 0 | 0 | $0 |
| Greg Roth | President-Ambulatory Surgery | 31 Ottobre 2004 D | 9.029 | 0 | 0 | $0 |
| Jay Grinney | President-Eastern Group | 07 Maggio 2004 D | 24.177 | 0 | 0 | $0 |
| Jon M Foster | EVP and COO | 10 Febbraio 2026 F | 23.062 | 0 | 0 | $0 |
| Michael R Mcalevey | EVP & Chief Legal & Admin Off. | 13 Febbraio 2026 M | 8.853 | 0 | 2 | $-2.747.520 |
| Jennifer Berres | SVP & Chief Human Res. Officer | 11 Febbraio 2026 S | 11.993 | 0 | 2 | $-4.126.932 |
| Christopher F. Wyatt | SVP & Controller | 11 Febbraio 2026 S | 44.379 | 0 | 1 | $-2.020.000 |
| Erica Rossitto | SVP & Chief Nurse Executive | 10 Febbraio 2026 F | 10.407 | 0 | 0 | $0 |
| Michael S. Cuffe | EVP and Chief Clinical Officer | 10 Febbraio 2026 F | 32.080 | 0 | 1 | $-747.135 |
| Sammie S Mosier | SVP & Chief Nurse Executive | 13 Febbraio 2025 F | 11.113 | 0 | 0 | $0 |
| Kathleen M Whalen | SVP & Chief Ethics Officer | 14 Novembre 2024 S | 9.454 | 0 | 0 | $0 |
| Phillip G Billington | SVP-Internal Audit Services | 12 Novembre 2024 M | 52.702 | 0 | 0 | $0 |
| Joseph A Sowell III | SVP; Chief Development Officer | 05 Agosto 2024 G | 18.526 | 0 | 0 | $0 |
| Deborah M Reiner | SVP - Mktg. & Communications | 29 Luglio 2024 S | 3.510 | 0 | 0 | $0 |
| Kathryn A. Torres | SVP-Payer Contracting & Align. | 25 Luglio 2024 S | 17.755 | 0 | 0 | $0 |
| Jeffrey E. Cohen | SVP-Government Relations | 09 Maggio 2024 S | 5.185 | 0 | 0 | $0 |
| Chad J Wasserman | SVP and CIO | 18 Marzo 2024 M | 1.576 | 0 | 0 | $0 |
| Martin P. Paslick | SVP and CIO | 12 Aprile 2023 M | 24.643 | 0 | 0 | $0 |
| Jane D. Englebright | SVP and Chief Nursing Officer | 09 Novembre 2021 S | 0 | 0 | 0 | $0 |
| Robert A Waterman | SVP & General Counsel | 05 Maggio 2021 S | 50.062 | 0 | 0 | $0 |
| William J Morrow | SVP - Finance and Treasurer | 18 Febbraio 2021 F | 5.578 | 0 | 0 | $0 |
| Sandra L. Morgan | SVP-Provider Relations | 18 Febbraio 2021 F | 10.122 | 0 | 0 | $0 |
| Victor L Campbell | SVP-Government Affairs | 01 Maggio 2019 A | 194.145 | 0 | 0 | $0 |
| John M Steele | SVP & Chief Human Res. Officer | 25 Febbraio 2019 M | 84.157 | 0 | 0 | $0 |
| Milton R Johnson | Chairman | 25 Febbraio 2019 M | 881.823 | 0 | 0 | $0 |
| Ravi S. Chari | SVP-Clinical Excellence | 25 Febbraio 2018 M | 7.003 | 0 | 0 | $0 |
| Alan R Yuspeh | SVP & Chief Ethics Officer | 25 Febbraio 2018 M | 35.546 | 0 | 0 | $0 |
| Joseph N Steakley | SVP-Internal Audit Services | 25 Febbraio 2018 M | 65.199 | 0 | 0 | $0 |
| Jana Joustra Davis | SVP - Mktg. & Corp. Affairs | 23 Maggio 2017 M | 26.378 | 0 | 0 | $0 |
| David Gwin Anderson | SVP - Finance | 07 Novembre 2016 M | 110.167 | 0 | 0 | $0 |
| Donald W Stinnett | SVP & Controller | 25 Febbraio 2016 A | 51.965 | 0 | 0 | $0 |
| Noel B Williams | SVP and CIO | 16 Maggio 2012 M | 299.030 | 0 | 0 | $0 |
| Jack O Bovender JR | Chairman | 06 Ottobre 2009 A | 188.340 | 0 | 0 | $0 |
| Carl V George | SVP - Development | 27 Febbraio 2009 M | 13.092 | 0 | 0 | $0 |
Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato
Attivisti e proprietari del 5%+ 4 partecipazioni
Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.
| Depositante | Depositato | Partecipazione | Stato | Scopo | Deposito |
|---|---|---|---|---|---|
| Frisco Holding II, Hercules Holding II, Thomas F. Frist, Jr., Thomas F. Frist III, William R. Frist, Patricia F. Elcan | 10 Febbraio 2026 | 31,60% | Deposito iniziale | — | SEC |
| 22 Novembre 2006 | — | Deposito iniziale | — | SEC | |
| Merrill Lynch Bank USA | 11 Settembre 2006 | — | Deposito iniziale | — | SEC |
| Frisco, Inc., Frisco Partners, Thomas F. Frist, Jr., Patricia Champion Frist, Patricia Frist Elcan, William Robert Frist, Thomas F. Frist III, Merrill Lynch Professional Clearing Corp., Merrill Lynch, Pierce, Fenner & Smith Incorporated, Merrill Lynch Financial Markets, Inc., Merrill Lynch International, Merrill Lynch & Co., Inc., Merrill Lynch Trust Company, FSB, Citigroup Inc.*, Bank of America Corporation, NB Holdings Corporation, NationsBanc Montgomery Holdings Corporation, Banc of America Securities LLC | 04 Agosto 2006 | — | Deposito iniziale | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Proprietà ETF Posseduti da 207 ETF
Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.
| Fondo | Peso | Unità | Aggiornato al | Fonte |
|---|---|---|---|---|
| IHF · iShares Trust | 4,67% | 141.320 SH | 08 Agosto 2026 | Giornaliero |
| BUL · Pacer Funds Trust | 3,91% | 11.437 NS | 30 Aprile 2026 | N-PORT |
| YALL · Tidal Trust I | 3,61% | 9.261 NS | 31 Maggio 2026 | N-PORT |
| BWTG · ETF Opportunities Trust | 3,02% | 1.646 NS | 31 Maggio 2026 | N-PORT |
| PKW · Invesco Exchange-Traded Fund Trust | 2,32% | 99.335 SH | 08 Agosto 2026 | Giornaliero |
| ABIG · EA Series Trust | 2,00% | 2.938 NS | 29 Maggio 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 1,99% | 39.985 NS | 30 Aprile 2026 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,67% | 31.685 SH | 08 Agosto 2026 | Giornaliero |
| COWZ · Pacer Funds Trust | 1,64% | 688.264 NS | 30 Aprile 2026 | N-PORT |
| QQWZ · Pacer Funds Trust | 1,64% | 1.762 NS | 30 Aprile 2026 | N-PORT |
| FEGE · RBB Fund Trust | 1,46% | 74.706 NS | 31 Maggio 2026 | N-PORT |
| PWV · Invesco Exchange-Traded Fund Trust | 1,39% | 60.385 SH | 08 Agosto 2026 | Giornaliero |
| RPG · Invesco Exchange-Traded Fund Trust | 1,30% | 63.448 SH | 08 Agosto 2026 | Giornaliero |
| TMFE · RBB Fund, Inc. | 1,29% | 2.892 NS | 31 Maggio 2026 | N-PORT |
| AMID · EA Series Trust | 1,23% | 3.402 NS | 29 Maggio 2026 | N-PORT |
| FCPI · FIDELITY COVINGTON TRUST | 1,15% | 7.180 NS | 30 Aprile 2026 | N-PORT |
| FMAG · FIDELITY COVINGTON TRUST | 1,12% | 6.544 NS | 30 Aprile 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 1,12% | 73.639 NS | 30 Aprile 2026 | N-PORT |
| SRHQ · Elevation Series Trust | 1,10% | 4.883 NS | 30 Aprile 2026 | N-PORT |
| IYH · iShares Trust | 0,99% | 89.420 SH | 08 Agosto 2026 | Giornaliero |
| NEAR · iShares U.S. ETF Trust | 0,99% | 48.109.000 SH | 08 Agosto 2026 | Giornaliero |
| CURE · Direxion Shares ETF Trust | 0,98% | 3.122 NS | 30 Aprile 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,90% | 470.451 SH | 08 Agosto 2026 | Giornaliero |
| NFRA · FlexShares Trust | 0,88% | 62.176 NS | 30 Aprile 2026 | N-PORT |
| REVS · Columbia ETF Trust I | 0,87% | 5.693 NS | 30 Aprile 2026 | N-PORT |
| RXL · ProShares Trust | 0,86% | 1.632 NS | 31 Maggio 2026 | N-PORT |
| DIVB · iShares Trust | 0,85% | 36.806 SH | 08 Agosto 2026 | Giornaliero |
| BSCT · Invesco Exchange-Traded Self-Indexe… | 0,82% | 24.078.000 | 08 Agosto 2026 | Giornaliero |
| LSEQ · Harbor ETF Trust | 0,81% | 285 NS | 30 Aprile 2026 | N-PORT |
| IXJ · iShares Trust | 0,80% | 81.465 SH | 08 Agosto 2026 | Giornaliero |
| BSCS · Invesco Exchange-Traded Self-Indexe… | 0,76% | 26.493.000 | 08 Agosto 2026 | Giornaliero |
| SPVM · Invesco Exchange-Traded Fund Trust | 0,74% | 2.335 SH | 08 Agosto 2026 | Giornaliero |
| FTC · First Trust Exchange-Traded AlphaDE… | 0,73% | 21.329 NS | 30 Aprile 2026 | N-PORT |
| RFFC · ALPS ETF Trust | 0,68% | 533 NS | 31 Maggio 2026 | N-PORT |
| QUVU · Hartford Funds Exchange-Traded Trust | 0,68% | 2.698 NS | 30 Aprile 2026 | N-PORT |
| VFMF · VANGUARD WELLINGTON FUND | 0,67% | 12.075 SH | 08 Agosto 2026 | Giornaliero |
| VCEB · VANGUARD WORLD FUND | 0,62% | 8.146.000 PA | 08 Agosto 2026 | Giornaliero |
| FDMO · FIDELITY COVINGTON TRUST | 0,61% | 11.771 NS | 30 Aprile 2026 | N-PORT |
| RECS · Columbia ETF Trust I | 0,58% | 72.768 NS | 30 Aprile 2026 | N-PORT |
| AFLG · First Trust Exchange-Traded Fund VI… | 0,56% | 9.664 NS | 31 Maggio 2026 | N-PORT |
| VFVA · VANGUARD WELLINGTON FUND | 0,55% | 11.876 SH | 08 Agosto 2026 | Giornaliero |
| VLLU · Harbor ETF Trust | 0,54% | 54 NS | 30 Aprile 2026 | N-PORT |
| LSVD · ADVISORS' INNER CIRCLE FUND | 0,53% | 7.404 NS | 30 Aprile 2026 | N-PORT |
| WLDR · Two Roads Shared Trust | 0,51% | 844 NS | 30 Aprile 2026 | N-PORT |
| VALQ · AMERICAN CENTURY ETF TRUST | 0,50% | 4.620 NS | 31 Maggio 2026 | N-PORT |
| AKAF · ETF Series Solutions | 0,50% | 39 NS | 31 Maggio 2026 | N-PORT |
| BSCR · Invesco Exchange-Traded Self-Indexe… | 0,50% | 22.679.000 | 08 Agosto 2026 | Giornaliero |
| ROUS · Lattice Strategies Trust | 0,47% | 6.388 NS | 30 Aprile 2026 | N-PORT |
| VCLT · VANGUARD SCOTTSDALE FUNDS | 0,46% | 54.218.000 PA | 08 Agosto 2026 | Giornaliero |
| CGGR · Capital Group Growth ETF | 0,45% | 290.273 NS | 31 Maggio 2026 | N-PORT |